Jane Street’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.84M Sell
17,100
-44,300
-72% -$11M ﹤0.01% 3932
2025
Q4
$14.8M Buy
61,400
+9,200
+18% +$2.35M ﹤0.01% 1881
2025
Q3
$14.3M Buy
52,200
+34,200
+190% +$9.34M ﹤0.01% 1991
2025
Q2
$4.64M Sell
18,000
-24,400
-58% -$5.82M ﹤0.01% 3106
2025
Q1
$9.49M Buy
42,400
+23,300
+122% +$5.44M ﹤0.01% 2057
2024
Q4
$4.37M Sell
19,100
-29,500
-61% -$7.1M ﹤0.01% 2856
2024
Q3
$11.9M Buy
48,600
+8,700
+22% +$1.94M ﹤0.01% 1733
2024
Q2
$7.64M Buy
39,900
+2,300
+6% +$467K ﹤0.01% 2358
2024
Q1
$7.45M Sell
37,600
-10,700
-22% -$1.96M ﹤0.01% 2116
2023
Q4
$8.31M Buy
48,300
+600
+1% +$92.2K ﹤0.01% 2180
2023
Q3
$7.05M Buy
47,700
+44,500
+1,391% +$8.05M ﹤0.01% 2177
2023
Q2
$699K Buy
3,200
+900
+39% +$201K ﹤0.01% 5792
2023
Q1
$504K Sell
2,300
-2,400
-51% -$521K ﹤0.01% 6306
2022
Q4
$978K Sell
4,700
-20,300
-81% -$4.46M ﹤0.01% 5018
2022
Q3
$5.46M Sell
25,000
-42,400
-63% -$9.65M ﹤0.01% 2471
2022
Q2
$14.1M Buy
67,400
+13,600
+25% +$2.9M 0.01% 1408
2022
Q1
$13M Buy
53,800
+39,200
+268% +$9.48M ﹤0.01% 1663
2021
Q4
$3.8M Sell
14,600
-43,100
-75% -$11.2M ﹤0.01% 3288
2021
Q3
$15.2M Buy
57,700
+11,300
+24% +$3.09M 0.01% 1340
2021
Q2
$11.4M Buy
46,400
+37,900
+446% +$7.97M ﹤0.01% 1567
2021
Q1
$1.65M Sell
8,500
-3,100
-27% -$622K ﹤0.01% 4403
2020
Q4
$2.47M Sell
11,600
-55,100
-83% -$11M ﹤0.01% 3144
2020
Q3
$11.4M Buy
66,700
+26,300
+65% +$4.86M 0.01% 1118
2020
Q2
$7.76M Buy
40,400
+23,700
+142% +$3.88M 0.01% 1382
2020
Q1
$2.46M Buy
+16,700
New +$2.66M ﹤0.01% 1810
2019
Q1
Sell
-7,000
Closed -$797K 5527
2018
Q4
$797K Buy
+7,000
New +$750K ﹤0.01% 2882

Other funds holding RMD

Jane Street's RMD Position: Q1 2026 in Review

Jane Street increased its ResMed (RMD) stake by 27% in Q1 2026, buying an estimated $407K and bringing the position to 7,589 shares worth $1.7M. The position accounts for ﹤0.01% of the portfolio, ranked #5398.

Jane Street first reported a position in RMD in Q2 2013 and has held it in 42 quarters since. The position peaked at $91.2M in Q4 2023. 939 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • Jane Street held 7,589 shares of ResMed worth $1.7M as of Q1 2026.
  • Jane Street bought 1,634 ResMed shares in Q1 2026, an estimated $407K.
  • ResMed made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #5398 holding.
  • Jane Street first reported a position in ResMed in Q2 2013 and has held it in 42 quarters since.
  • Jane Street's ResMed position peaked at $91.2M in Q4 2023.
  • 939 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.